Related Experiment Video
Updated: Sep 25, 2025

Development of a Murine Model for Femoral Artery Anastomotic Stenosis
Published on: April 18, 2025
Computational Fluid Dynamics for the Prediction of Endograft Thrombosis in the Superficial Femoral Artery
Lennart van de Velde1,2,3, Erik Groot Jebbink1,2, Rob Hagmeijer4
1Department of Surgery, Ziekenhuis Rijnstate, Arnhem, The Netherlands.
Insights
Computational fluid dynamics (CFD) can predict endograft thrombosis, a complication not well-detected by current imaging. Low time-averaged wall shear stress (TAWSS) in CFD simulations correlated with endograft thrombosis in superficial femoral artery occlusive disease.
Area of Science:
- Vascular Surgery
- Biomedical Engineering
- Medical Imaging
Background:
- Endograft thrombosis is a significant complication after superficial femoral artery (SFA) interventions.
- Current diagnostic tools like CTA and duplex ultrasound have limitations in predicting endograft thrombosis.
- Understanding the hemodynamic factors contributing to thrombosis is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the potential of image-based computational fluid dynamics (CFD) for predicting endograft thrombosis.
- To explore the relationship between hemodynamic parameters and endograft thrombosis in SFA occlusive disease.
- To assess if personalized CFD can identify patients at risk for endograft thrombosis.
Main Methods:
- Retrospective analysis of four patients treated with endografts for SFA occlusion.
- CFD simulations were performed using data from contrast-enhanced computed tomography angiography (CTA) and duplex ultrasound.
- Time-averaged wall shear stress (TAWSS) was computed to evaluate flow patterns within the endografts.
Main Results:
- CFD simulations revealed low TAWSS (<0.4 Pa) in patients who developed endograft thrombosis (Cases 3 and 4).
- Patients with normal TAWSS (>0.4 Pa) achieved primary patency for over two years (Cases 1 and 2).
- Recurrent endograft thrombosis occurred in patients with low TAWSS despite normal anatomical and ultrasound findings.
Conclusions:
- Low TAWSS, identified through CFD, is associated with recurrent endograft thrombosis.
- CFD offers a promising tool for predicting endograft thrombosis, especially when conventional assessments are normal.
- Personalized CFD analysis can enhance risk stratification for endograft thrombosis in SFA disease.
Purpose:
Contemporary diagnostic modalities, including contrast-enhanced computed tomography (CTA) and duplex ultrasound, have been insufficiently able to predict endograft thrombosis. This study introduces an implementation of image-based computational fluid dynamics (CFD), by exemplification with 4 patients treated with an endograft for occlusive disease of the superficial femoral artery (SFA). The potential of personalized CFD for predicting endograft thrombosis is investigated.
Materials And Methods:
Four patients treated with endografts for an occluded SFA were retrospectively included. CFD simulations, based on CTA and duplex ultrasound, were compared for patients with and without endograft thrombosis to investigate potential flow-related causes of endograft thrombosis. Time-averaged wall shear stress (TAWSS) was computed, which highlights areas of prolonged residence times of coagulation factors in the graft.
Results:
CFD simulations demonstrated normal TAWSS (>0.4 Pa) in the SFA for cases 1 and 2, but low levels of TAWSS (<0.4 Pa) in cases 3 and 4, respectively. Primary patency was achieved in cases 1 and 2 for over 2 year follow-up. Cases 3 and 4 were complicated by recurrent endograft thrombosis.
Conclusion:
The presence of a low TAWSS was associated with recurrent endograft thrombosis in subjects with otherwise normal anatomic and ultrasound assessment and a good distal run-off.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023